Evidence map›Paper›PMID 27114548›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Origin and evolution of developmental enhancers in the mammalian neocortex.

Deena Emera, Jun Yin, Steven K Reilly, Jake Gockley, James P Noonan

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Regulatory activity is the default DNA state in eukaryotes.Nature structural & molecular biology · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Deena EmeraDepartment of Genetics, Yale School of Medicine, New Haven, CT;
Jun YinDepartment of Genetics, Yale School of Medicine, New Haven, CT;
Steven K ReillyDepartment of Genetics, Yale School of Medicine, New Haven, CT;
Jake GockleyDepartment of Genetics, Yale School of Medicine, New Haven, CT;
James P NoonanDepartment of Genetics, Yale School of Medicine, New Haven, CT; Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT 06510; Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT 06511 james.noonan@yale.edu.
Yale University · US

Funding

GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
Identifying enhancers with human-specific developmental functionsR01GM094780 · NIGMS · YALE UNIVERSITY · PI NOONAN, JAMES P · 2010 to 2018
$5.8M
Regulatory Innovations Driving the Evolution of the Mammalian NeocortexF32GM106628 · NIGMS · YALE UNIVERSITY · PI EMERA, DEENA · 2013 to 2015
$159k
Medical Research Council G0700089Medical Research Council MC_PC_15004NICHD NIH HHS T32 HD007149NIGMS NIH HHS F32 GM106628NIGMS NIH HHS R01 GM094780
6 · The paper itself

Abstract

Morphological innovations such as the mammalian neocortex may involve the evolution of novel regulatory sequences. However, de novo birth of regulatory elements active during morphogenesis has not been extensively studied in mammals. Here, we use H3K27ac-defined regulatory elements active during human and mouse corticogenesis to identify enhancers that were likely active in the ancient mammalian forebrain. We infer the phylogenetic origins of these enhancers and find that ∼20% arose in the mammalian stem lineage, coincident with the emergence of the neocortex. Implementing a permutation strategy that controls for the nonrandom variation in the ages of background genomic sequences, we find that mammal-specific enhancers are overrepresented near genes involved in cell migration, cell signaling, and axon guidance. Mammal-specific enhancers are also overrepresented in modules of coexpressed genes in the cortex that are associated with these pathways, notably ephrin and semaphorin signaling. Our results also provide insight into the mechanisms of regulatory innovation in mammals. We find that most neocortical enhancers did not originate by en bloc exaptation of transposons. Young neocortical enhancers exhibit smaller H3K27ac footprints and weaker evolutionary constraint in eutherian mammals than older neocortical enhancers. Based on these observations, we present a model of the enhancer life cycle in which neocortical enhancers initially emerge from genomic background as short, weakly constrained "proto-enhancers." Many proto-enhancers are likely lost, but some may serve as nucleation points for complex enhancers to evolve.

Indexed as

Biological EvolutionAnimalsBase SequenceComputer SimulationEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalHumansMiceModels, GeneticMorphogenesisNeocortexSpecies SpecificityTranscription FactorsTranscription Factorsbrain evolutionepigeneticsneocortical developmentregulatory innovation

Identifiers

PMID27114548
PMCPMC4868431
OpenAlexW2344758159

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.